By Marika Sboros
If you think robust evidence of serious health risks has dealt a terminal blow to the billion-dollar statin industry’s heart, think again. Statins are still the world’s most prescribed drug and the drug industry’s most profitable medicine ever.
In a new meta-analysis in The Lancet, UK scientists attempt CPR on the drug’s ailing reputation. They want doctors to prescribe statins to more people over 75. They say that doing so will save 8000 lives annually. (That’s after some experts calling for doctors to put just about everyone, including children, on the drugs.) The authors also claim that statins produce “significant reductions in vascular events (heart attack and stroke) irrespective of age”.
Independent researchers say those are false claims and the study is riddled with terminal errors. They also say the authors remain hopelessly conflicted with long-term links with drug companies.